Repligen Corporation to Present at Evercore Healthcare Conference

Rhea-AI Summary

Repligen (NASDAQ:RGEN) will participate in the 8th Annual Evercore Healthcare Conference taking place Dec 2–4, 2025 in Coral Gables, Florida.

Jason Garland, Chief Financial Officer, will join an analyst-led discussion on Dec 3, 2025 at 1:20 p.m. ET. A live webcast will be available on Repligen’s Investor Relations website at www.repligen.com, with a limited-time replay following the event.

WALTHAM, Mass., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be participate in the 8^th Annual Evercore Healthcare Conference, being held December 2 -4 in Coral Gables, Florida. Jason Garland, Chief Financial Officer, will participate in an analyst-led discussion on December 3^rd at 1:20 p.m. ET.

A live webcast of the conference presentations will be accessible through Repligen’s Investor Relations website at www.repligen.com, and will be available for replay for a limited period of time following the event.

About Repligen Corporation
Repligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs. We are “inspiring advances in bioprocessing” for the customers we serve; primarily biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide. Our focus areas are Filtration and Fluid Management, Chromatography, Process Analytics and Proteins. Our corporate headquarters are located in Waltham, Massachusetts, and the majority of our manufacturing sites are in the U.S., with additional key sites in Estonia, France, Germany, Ireland, the Netherlands and Sweden. For more information about the our company see our website at www.repligen.com, and follow us on LinkedIn.

Repligen Contact:
Jacob Johnson
VP, Investor Relations
781-419-0204
investors@repligen.com

FAQ

When will Repligen (RGEN) present at the Evercore Healthcare Conference in 2025?

Repligen will participate at the conference Dec 2–4, 2025, with a CFO discussion on Dec 3, 2025 at 1:20 p.m. ET.

Who from Repligen (RGEN) will speak at the Evercore Healthcare Conference?

Jason Garland, Repligen’s Chief Financial Officer, will participate in the analyst-led discussion.

How can investors watch Repligen (RGEN) presentations from the Evercore conference?

A live webcast will be accessible via Repligen’s Investor Relations website at www.repligen.com, with a limited-time replay available after the event.

What is the schedule for Repligen’s (RGEN) analyst-led discussion at Evercore?

The analyst-led discussion is scheduled for Dec 3, 2025 at 1:20 p.m. ET.

Where is the 8th Annual Evercore Healthcare Conference being held for Repligen (RGEN)?

The conference is being held in Coral Gables, Florida from Dec 2–4, 2025.

Will Repligen (RGEN) make the Evercore presentation available after the live event?

Yes. A replay will be available on the company Investor Relations site for a limited period following the event.